The protective effects of Lipoxin A4during the early phase of severe acute pancreatitis in rats
- 18 October 2010
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 46 (2) , 211-219
Abstract
Objective. Our aim was to investigate the protective effects of a Lipoxin A4 analogue (LXA4) in the early phase of acute pancreatitis in rats. Materials and methods. Severe acute pancreatitis (SAP) was induced by injection of 5% sodium taurocholate into the pancreatic duct. Rats with SAP were treated with LXA4 (0.1 mg/kg), 10 min after the 5% sodium taurocholate injection, after which LXA4 was administrated every 8 hours, three times (LXA4 group). The sham group was only given the vehicle after operation. Plasma amylase activity, serum levels of interleukin-1 (IL-1), IL-6, and tumor necrosis factor-α (TNF-α) were measured at 4, 12, and 24 h after induction of SAP. The pancreatic index and histopathologic observations were evaluated and the expression of intercellular adhesion molecule-1 (ICAM-1) and NF-κB p65 in the pancreas, and the expression of ICAM-1 in the lungs were detected by immunohistochemistry. Results. LXA4 treated rats had lower serum levels of TNF-α, IL-1, and IL-6 at all time points measured (p < 0.05), but significantly differed in plasma amylase activity only at 24 h as compared with the SAP group. The pancreatic index and the scores of pancreatitic histopathologic evaluations were lower in the LXA4 group as compared to the SAP group. Immunohistochemistry showed that LXA4 attenuated the expression of ICAM-1 and NF-κB p65 in the pancreas, as well as the expression of ICAM-1 in the lungs in animals with pancreatitis (p < 0.05). Conclusions. We demonstrate that LXA4 has protective effects in experimental SAP, which may be achieved by inhibiting the NF-κB signalling pathway, thereby reducing the production of proinflammatory cytokines.Keywords
This publication has 35 references indexed in Scilit:
- Systemic Inflammatory Response Syndrome in Nonhuman Primates Culminating in Multiple Organ Failure, Acute Lung Injury, and Disseminated Intravascular CoagulationToxicologic Pathology, 2009
- Lipoxin A4 inhibits IL-1β-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cellsAmerican Journal of Physiology-Cell Physiology, 2009
- Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient miceProceedings of the National Academy of Sciences, 2008
- Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammationJournal of Leukocyte Biology, 2008
- Aromatic Lipoxin A4and Lipoxin B4Analogues Display Potent Biological ActivitiesJournal of Medicinal Chemistry, 2007
- Continuous veno-venous haemofiltration in the treatment of severe acute pancreatitis: 6-year experienceHPB, 2007
- Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Activation of NF-κB-dependent gene expression by Salmonella flagellins FliC and FljBBiochemical and Biophysical Research Communications, 2007
- A Better Model of Acute Pancreatitis for Evaluating TherapyAnnals of Surgery, 1992
- Experimental Pancreatitis in the RatScandinavian Journal of Gastroenterology, 1980